Surge in Melatonin Sleep Aid Sales

The global melatonin market is experiencing significant growth, driven by a rising prevalence of sleep disorders, lifestyle-related stress, and an increasing consumer preference for natural supplements over prescription medications.

Market projections vary by analyst, but industry data indicates a strong upward trajectory. One forecast suggests the market will be valued at USD 2.8 billion in 2025 and is expected to reach USD 6.6 billion by 2035, representing a compound annual growth rate (CAGR) of 9%.

Other industry estimates provide different valuations for the near term. DataM Intelligence projects the market size will reach USD 1.89 billion in 2025 and grow to USD 3.0 billion by 2030, with a CAGR of 9.67%. Strategic Market Research estimates the market was USD 2.1 billion in 2024 and is projected to reach USD 3.1 billion by 2030, growing at a CAGR of 6.7%.

Market Drivers and Consumer Trends

The surge in demand is attributed to several global health and lifestyle factors. Increasing awareness of circadian rhythm health and the occurrence of sleep disorders, including insomnia and jet lag, have pushed melatonin from a niche product to mainstream adoption in the wellness, nutraceutical, and pharmaceutical industries.

The elderly population is identified as a key driver for the supplement industry. Because older adults often experience naturally decreasing levels of melatonin, supplements are marketed as safer, non-addictive alternatives to traditional sleeping pills.

Technological advancements in product delivery are also contributing to growth. The development of extended-release products specifically for elderly consumers has expanded the market. The rise of e-commerce has improved consumer access to a wider variety of sleep health products and information.

Product Types and Medical Applications

Synthetic melatonin dominates the market in terms of revenue. In 2025, synthetic versions generated more than 70% of revenues, totaling approximately USD 1.3 billion. This dominance is attributed to large-scale industrial production, which ensures cost efficiency and wide availability for over-the-counter products and dietary supplements.

Beyond general sleep aids, the market is expanding into specialized formulations and medical applications. These include:

• Gummies and chewables, including pediatric-safe formulations.
• Extended-release products for the elderly.
• Clinical applications in neurology, oncology, and immune health.
• Circadian rhythm regulators for business travelers dealing with jet lag.

Industry Players and Global Production

Major global companies such as Nature’s Bounty, Natrol, Pfizer, and BASF are actively expanding their portfolios to meet the increasing demand for tailor-made sleep solutions.

Production is also scaling in Asia, particularly in China, where biotech firms are increasing the manufacture of both synthetic and natural melatonin to support global supply.

Safety and Regulatory Considerations

While the market expands, safety concerns regarding specific formulations have emerged. Reports indicate that children can overdose on melatonin gummies, leading some online stores to suspend sales of certain products.

In the United States, various synthetic melatonin preparations are widely available over the counter. Historical data from 2012 to 2021 shows a steady increase in the sales of these preparations.

Changes in regulations within major industries are currently positioning supplements for increased visibility, which continues to expand the overall size of the industry.